Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

433998

registered interest
date	03/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Multiple Myeloma
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether an assessment has been made of the barriers preventing multiple myeloma patients accessing the most innovative treatments.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	18708
answer	answer is ministerial correction date of answer 11/12/2015 answer text <p>No specific assessment has been made of the barriers affecting access to the most innovative treatments for patients with multiple myeloma.</p><br /><p>It is essential that a robust process is in place to ensure that patients get rapid access to the most innovative drugs that represent value for money to the National Health Service. The Cancer Drugs Fund has helped over 84,000 people to access the life-extending drugs they need, and NHS England and the National Institute for Health and Care Excellence are currently consulting on the future shape of the Fund to put it on a more sustainable footing.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 11/12/2015 12:18:24 answering member 3918 label Biography information for Jane Ellison
tabling member	3960 label Biography information for Henry Smith

386885

registered interest
date	01/07/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Multiple Myeloma
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government when they expect the National Institute of Health Research Technology Assessment programme to publish initial findings from its assessment of the benefits of antibiotic prophylaxis and its effect on healthcare associated infections in myeloma patients.
tabling member printed	Lord Willis of Knaresborough
uin	HL994
answer	answer is ministerial correction date of answer 09/07/2015 answer text <p>This trial is led by the University of Birmingham. The project is recruiting ahead of schedule and expects to reach its target of 800 in the near future. The target was to do so by the end of November 2015. Publication of initial findings is expected in 2017.</p><p> </p> answering member printed Lord Prior of Brampton question first answered 09/07/2015 13:00:57 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	4151 label Biography information for Lord Willis of Knaresborough